Historical return extremes for AstraZeneca (AZN) from 1993 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +6,895% | $2.98 | $208.45 | $69,949.66 | ||
| Max drawdownMore info about Max drawdown | -49.22% | $31.25 | $15.87 | $507.84 | ||
| Return since IPOMore info about Return since IPO | +5,236% | $3.35 | $178.75 | $53,358.21 |
- Max profitMore info about Max profit+6,895%$69,949.66
- Max drawdownMore info about Max drawdown-49.22%$507.84
- Return since IPOMore info about Return since IPO+5,236%$53,358.21
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in AstraZeneca (AZN). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement